AU2001262786A1 - Use of l-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes - Google Patents

Use of l-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes

Info

Publication number
AU2001262786A1
AU2001262786A1 AU2001262786A AU2001262786A AU2001262786A1 AU 2001262786 A1 AU2001262786 A1 AU 2001262786A1 AU 2001262786 A AU2001262786 A AU 2001262786A AU 2001262786 A AU2001262786 A AU 2001262786A AU 2001262786 A1 AU2001262786 A1 AU 2001262786A1
Authority
AU
Australia
Prior art keywords
oxothiazolidine
diabetes
treatment
type
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262786A
Inventor
Myung-Kwan Han
Uh-Hyun Kim
Kum-Jae Park
Kwang-Hyun Park
Young-Mi Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Biochemicals Inc
Original Assignee
Advanced Biochemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biochemicals Inc filed Critical Advanced Biochemicals Inc
Publication of AU2001262786A1 publication Critical patent/AU2001262786A1/en
Abandoned legal-status Critical Current

Links

AU2001262786A 2001-02-14 2001-06-05 Use of l-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes Abandoned AU2001262786A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR2001/7366 2001-02-14

Publications (1)

Publication Number Publication Date
AU2001262786A1 true AU2001262786A1 (en) 2002-08-28

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
AU2001292480A1 (en) Novel pyridazine compounds for the treatment of diabetes
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2002350966A1 (en) Heart monitor
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
PL373723A1 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2021601A (en) Composition for the treatment of dandruff
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
AU2002327440A1 (en) Treatment of type i diabetes
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
AU2001262786A1 (en) Use of l-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes
EP1177789A3 (en) Use of phytanic acid for the treatment of diabetes
AU7756900A (en) Treatment of chemical hydrolysates
GB0212790D0 (en) Medicament for the treatment of diabetes
AU2003223098A1 (en) Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
AU2003273192A1 (en) Compounds and compositions for the treatment of diabetes and diabetes-related disorders
AU2002358102A1 (en) Use of 7-monohydroxyethylrutoside for the treatment of haematological disorders, particurlarly beta-thalassemia
AU2002312779A1 (en) Delta-aminolevulinic acid for the therapeutical and cosmetic use